Head injury, alpha‐synuclein Rep1, and Parkinson's disease
- 2 June 2011
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 71 (1), 40-48
- https://doi.org/10.1002/ana.22499
Abstract
Objective: To test the hypothesis that variability in SNCA Rep1, a polymorphic dinucleotide microsatellite in the promoter region of the gene encoding α‐synuclein, modifies the association between head injury and Parkinson's disease (PD) risk. Methods: Participants in the Farming and Movement Evaluation (FAME) and the Study of Environmental Association and Risk of Parkinsonism using Case‐Control Historical Interviews (SEARCH), 2 independent case‐control studies, were genotyped for Rep1 and interviewed regarding head injuries with loss of consciousness or concussion prior to Parkinson's disease (PD) diagnosis. Logistic regression modeling adjusted for potential confounding variables and tested interaction between Rep1 genotype and head injury. Results: Consistent with prior reports, relative to medium‐length Rep1, short Rep1 genotype was associated with reduced PD risk (pooled odds ratio [OR], 0.7; 95% confidence interval [CI], 0.5–0.9), and long Rep1 with increased risk (pooled OR, 1.4; 95% CI, 0.95–2.2). Overall, head injury was not significantly associated with PD (pooled OR, 1.3; 95% CI, 0.9–1.8). However, head injury was strongly associated with PD in those with long Rep1 (FAME OR, 5.4; 95% CI, 1.5–19; SEARCH OR, 2.3; 95% CI, 0.6–9.2; pooled OR, 3.5; 95% CI 1.4–9.2, p‐interaction = 0.02). Individuals with both head injury and long Rep1 were diagnosed 4.9 years earlier than those with neither risk factor (p = 0.03). Interpretation: While head injury alone was not associated with PD risk, our data suggest head injury may initiate and/or accelerate neurodegeneration when levels of synuclein are high, as in those with Rep1 expansion. Given the high population frequency of head injury, independent verification of these results is essential. ANN NEUROL 2012;71:40–48Keywords
This publication has 69 references indexed in Scilit:
- Rotenone, Paraquat, and Parkinson’s DiseaseEnvironmental Health Perspectives, 2011
- Genetic Regulation of α-Synuclein mRNA Expression in Various Human Brain TissuesPLOS ONE, 2009
- Expansion of the Parkinson disease-associated SNCA- Rep1 allele upregulates human α-synuclein in transgenic mouse brainHuman Molecular Genetics, 2009
- Distinct Cellular Patterns of Upregulated Chemokine Expression Supporting a Prominent Inflammatory Role in Traumatic Brain InjuryJournal of Neurotrauma, 2008
- Exploring gene-environment interactions in Parkinson’s diseaseHuman Genetics, 2008
- Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humansExperimental Neurology, 2007
- Calpain-Cleavage of α-Synuclein: Connecting Proteolytic Processing to Disease-Linked AggregationThe American Journal of Pathology, 2007
- Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson studyOccupational and Environmental Medicine, 2007
- Cerebrovascular Changes in a Rat Model of Moderate Closed-Head InjuryJournal of Neurotrauma, 1991
- Attributable risk percent in case-control studies.Journal of Epidemiology and Community Health, 1971